Rio999的个人主页 - 老虎社区

Rio999

Rio999

Stay foolish

IP属地：未知

148关注

17粉丝

5主题

0勋章

08-03

川登之争，只是影响比特币三个月的摇摆。谁上了，又只是四年任期而已。

2022-05-12

稳住了沧海横流

港股CXO概念股持续拉升，药明生物涨近10%，金斯瑞生物科技涨近8%，昭衍...

2022-03-17

$金斯瑞生物科技(01548)$my heart echos

2022-03-14

$金斯瑞生物科技(01548)$看好小金。少量加仓成功。战争一定会结束。小金应该对香港和大陆疫情有正面贡献。只是金融对抗貌似开始啦

2022-03-01

$传奇生物(LEGN)$里程碑式的一天。

2022-03-01

$金斯瑞生物科技(01548)$批准。里程碑的一天

2022-02-23

$金斯瑞生物科技(01548)$什么时候见40？哈哈今天30，40还会远吗

2022-02-18

淋巴癌不容易。主动暂停临床，是诚实公司的表现。调整配方后，继续实验。a good try anyway

Legend Biotech slips after FDA clinical hold on blood cancer study for CAR-T therapy

2022-02-18

$金斯瑞生物科技(01548)$再也挡不住了

2022-02-11

$金斯瑞生物科技(01548)$祝贺小金，though今天大跌。

2022-02-08

$金斯瑞生物科技(01548)$元宵节行情谁预测一下。

2022-01-11

激励非常重要。

金斯瑞生物科技向轮值首席执行官柳振宇授予约16.44万股限制性股份

2022-01-10

$金斯瑞生物科技(01548)$大腿粗了细了，最终还是粗了

2022-01-10

$金斯瑞生物科技(01548)$好赛道好兆头

2021-12-07

节奏掌握得不错，高人

金斯瑞生物科技(01548.HK)非全资附属向日本提交骨髓瘤新药申请

2021-12-07

造福各国患者

金斯瑞生物科技(01548.HK)非全资附属向日本提交骨髓瘤新药申请

2021-11-18

$Roblox Corporation(RBLX)$伟大的游戏公司，游戏生态。而游戏精神，包括游戏的教育性，动手性，影响深远。游戏，不仅少儿尿泥时。

2021-11-16

$金斯瑞生物科技(01548)$跑百里者半九十

2021-11-15

$传奇生物(LEGN)$再次冲击50

2021-11-12

问题不大。

港股电子烟概念午后拉涨，华宝国际一度涨超21%

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3486361727758741","uuid":"3486361727758741","gmtCreate":1523338620951,"gmtModify":1636603757954,"name":"Rio999","pinyin":"rio999","introduction":"","introductionEn":null,"signature":"Stay foolish","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","hat":"https://static.tigerbbs.com/64cc74234f338af2bc1439cca864443e","hatId":"mid_autumn_head_frame","hatName":"goods_40_name","vip":1,"status":2,"fanSize":17,"headSize":148,"tweetSize":244,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":5,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":12,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.49%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.29%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":2,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":334304863559920,"gmtCreate":1722650476291,"gmtModify":1722652573417,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"川登之争，只是影响比特币三个月的摇摆。谁上了，又只是四年任期而已。","listText":"川登之争，只是影响比特币三个月的摇摆。谁上了，又只是四年任期而已。","text":"川登之争，只是影响比特币三个月的摇摆。谁上了，又只是四年任期而已。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/334304863559920","isVote":1,"tweetType":1,"viewCount":1153,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":612645906,"gmtCreate":1652338203705,"gmtModify":1652338205030,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"稳住了 沧海横流","listText":"稳住了 沧海横流","text":"稳住了 沧海横流","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/612645906","repostId":"2234869608","repostType":2,"repost":{"id":"2234869608","pubTimestamp":1652238388,"share":"https://www.laohu8.com/m/news/2234869608?lang=&edition=full","pubTime":"2022-05-11 11:06","market":"us","language":"zh","title":"港股CXO概念股持续拉升，药明生物涨近10%，金斯瑞生物科技涨近8%，昭衍...","url":"https://stock-news.laohu8.com/highlight/detail?id=2234869608","media":"媒体滚动","summary":"港股CXO概念股持续拉升，药明生物涨近10%，金斯瑞生物科技涨近8%，昭衍新药涨超8%，泰格医药、药明康德涨超5%，康龙化成涨近5%，凯莱英涨近4%。","content":"<html><body><p>港股CXO概念股持续拉升，<a href=\"https://laohu8.com/S/02269\">药明生物</a>涨近10%，<a href=\"https://laohu8.com/S/01548\">金斯瑞生物科技</a>涨近8%，<a href=\"https://laohu8.com/S/603127\">昭衍新药</a>涨超8%，<a href=\"https://laohu8.com/S/300347\">泰格医药</a>、<a href=\"https://laohu8.com/S/WX\">药明康德</a>涨超5%，<a href=\"https://laohu8.com/S/300759\">康龙化成</a>涨近5%，<a href=\"https://laohu8.com/S/002821\">凯莱英</a>涨近4%。</p></body></html>","source":"sina_symbol","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股CXO概念股持续拉升，药明生物涨近10%，金斯瑞生物科技涨近8%，昭衍...</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股CXO概念股持续拉升，药明生物涨近10%，金斯瑞生物科技涨近8%，昭衍...\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-11 11:06 北京时间&nbsp;&nbsp;&nbsp;<a href=https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-05-11/doc-imcwiwst6777997.shtml><strong>媒体滚动</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>港股CXO概念股持续拉升，药明生物涨近10%，金斯瑞生物科技涨近8%，昭衍新药涨超8%，泰格医药、药明康德涨超5%，康龙化成涨近5%，凯莱英涨近4%。</p>\n\n<a href=\"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-05-11/doc-imcwiwst6777997.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"01548":"金斯瑞生物科技","BK1141":"生命科学工具和服务","BK1521":"挪威政府全球养老基金持仓","BK1576":"医药外包概念","06127":"昭衍新药","02269":"药明生物","CXO":"康休","BK1583":"高瓴概念","BK1589":"北水核心资产"},"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/7x24/2022-05-11/doc-imcwiwst6777997.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2234869608","content_text":"港股CXO概念股持续拉升，药明生物涨近10%，金斯瑞生物科技涨近8%，昭衍新药涨超8%，泰格医药、药明康德涨超5%，康龙化成涨近5%，凯莱英涨近4%。","news_type":1},"isVote":1,"tweetType":1,"viewCount":947,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":634640753,"gmtCreate":1647491089405,"gmtModify":1647491089690,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>my heart echos","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>my heart echos","text":"$金斯瑞生物科技(01548)$my heart echos","images":[{"img":"https://static.tigerbbs.com/dd160fa6897ec10ee129b0e7ccec8e59","width":"1200","height":"2140"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/634640753","isVote":1,"tweetType":1,"viewCount":935,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":635738467,"gmtCreate":1647244417989,"gmtModify":1647244418273,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>看好小金。少量加仓成功。战争一定会结束。小金应该对香港和大陆疫情有正面贡献。只是金融对抗貌似开始啦","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>看好小金。少量加仓成功。战争一定会结束。小金应该对香港和大陆疫情有正面贡献。只是金融对抗貌似开始啦","text":"$金斯瑞生物科技(01548)$看好小金。少量加仓成功。战争一定会结束。小金应该对香港和大陆疫情有正面贡献。只是金融对抗貌似开始啦","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/635738467","isVote":1,"tweetType":1,"viewCount":1088,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":636798768,"gmtCreate":1646092668866,"gmtModify":1646092669121,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LEGN\">$传奇生物(LEGN)$</a>里程碑式的一天。","listText":"<a href=\"https://laohu8.com/S/LEGN\">$传奇生物(LEGN)$</a>里程碑式的一天。","text":"$传奇生物(LEGN)$里程碑式的一天。","images":[{"img":"https://static.tigerbbs.com/18348eff34ce1ec3137c46f8bbcd41f4","width":"1200","height":"2640"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636798768","isVote":1,"tweetType":1,"viewCount":1055,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":636798884,"gmtCreate":1646092633895,"gmtModify":1646092634163,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>批准。里程碑的一天","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>批准。里程碑的一天","text":"$金斯瑞生物科技(01548)$批准。里程碑的一天","images":[{"img":"https://static.tigerbbs.com/18348eff34ce1ec3137c46f8bbcd41f4","width":"1200","height":"2640"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636798884","isVote":1,"tweetType":1,"viewCount":1015,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":636024765,"gmtCreate":1645596427460,"gmtModify":1645596427684,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>什么时候见40？哈哈 今天30，40还会远吗","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>什么时候见40？哈哈 今天30，40还会远吗","text":"$金斯瑞生物科技(01548)$什么时候见40？哈哈 今天30，40还会远吗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/636024765","isVote":1,"tweetType":1,"viewCount":889,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638839155,"gmtCreate":1645167456306,"gmtModify":1645167456563,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"淋巴癌 不容易。主动暂停临床，是诚实公司的表现。调整配方后，继续实验。a good try anyway","listText":"淋巴癌 不容易。主动暂停临床，是诚实公司的表现。调整配方后，继续实验。a good try anyway","text":"淋巴癌 不容易。主动暂停临床，是诚实公司的表现。调整配方后，继续实验。a good try anyway","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638839155","repostId":"2211631922","repostType":2,"repost":{"id":"2211631922","pubTimestamp":1644933391,"share":"https://www.laohu8.com/m/news/2211631922?lang=&edition=full","pubTime":"2022-02-15 21:56","market":"us","language":"en","title":"Legend Biotech slips after FDA clinical hold on blood cancer study for CAR-T therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2211631922","media":"seekingalpha","summary":"Grandbrothers/iStock Editorial via Getty Images   Legend Biotech (NASDAQ:LEGN) is trading ~6% lower ","content":"<html><body><p><figure> <picture> <img height=\"1024px\" src=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg?io=getty-c-w750\" srcset=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg?io=getty-c-w240 240w\" width=\"1536px\"/> </picture> <figcaption><p>Grandbrothers/iStock Editorial via Getty Images</p></figcaption> </figure></p> <ul> <li>Legend Biotech <span>(NASDAQ:LEGN)</span> is trading <span>~6% lower</span> in the pre-market on Tuesday after the company announced that the U.S<span> Food and Drug Administration (FDA) imposed a clinical hold on its Phase 1 trial for LB1901.</span> </li> <li>An autologous chimeric antigen receptor T-cell (CAR-T) therapy, LB1901, is designed to target cancerous CD4+ T-cells in the treatment of adults with relapsed or refractory T-cell lymphoma (TCL).</li> <li>The FDA informed its decision via e-mail on Feb. 11, and the federal agency had indicated that it would send the official clinical hold letter on Mar. 11, according to the company.</li> <li>Before the notification on clinical hold, the company had dosed only <a href=\"https://laohu8.com/S/AONE.U\">one</a> patient in the study. However, after the patient experienced low CD4+ T-cell counts, Legend (LEGN) had decided to pause the trial and notified the FDA.</li> <li>“The patient has not experienced drug-related serious adverse events (SAEs) and is being monitored in accordance with the protocol,” the company added. </li> <li><p>In October, Allogene <span>(NASDAQ:ALLO)</span> was slapped with a clinical hold by the FDA on its AlloCAR T trials. However, early this year, the company announced that the agency removed the clinical hold.</p></li> </ul></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Legend Biotech slips after FDA clinical hold on blood cancer study for CAR-T therapy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLegend Biotech slips after FDA clinical hold on blood cancer study for CAR-T therapy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 21:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3800074-legend-biotech-slips-after-fda-clinical-hold-on-blood-cancer-study-for-car-t-therapy><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Grandbrothers/iStock Editorial via Getty Images   Legend Biotech (NASDAQ:LEGN) is trading ~6% lower in the pre-market on Tuesday after the company announced that the U.S Food and Drug Administration (...</p>\n\n<a href=\"https://seekingalpha.com/news/3800074-legend-biotech-slips-after-fda-clinical-hold-on-blood-cancer-study-for-car-t-therapy\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LEGN":"传奇生物","BK4022":"陆运","BK4505":"高瓴资本持仓","BK4139":"生物科技","CAR":"安飞士"},"source_url":"https://seekingalpha.com/news/3800074-legend-biotech-slips-after-fda-clinical-hold-on-blood-cancer-study-for-car-t-therapy","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2211631922","content_text":"Grandbrothers/iStock Editorial via Getty Images   Legend Biotech (NASDAQ:LEGN) is trading ~6% lower in the pre-market on Tuesday after the company announced that the U.S Food and Drug Administration (FDA) imposed a clinical hold on its Phase 1 trial for LB1901.  An autologous chimeric antigen receptor T-cell (CAR-T) therapy, LB1901, is designed to target cancerous CD4+ T-cells in the treatment of adults with relapsed or refractory T-cell lymphoma (TCL). The FDA informed its decision via e-mail on Feb. 11, and the federal agency had indicated that it would send the official clinical hold letter on Mar. 11, according to the company. Before the notification on clinical hold, the company had dosed only one patient in the study. However, after the patient experienced low CD4+ T-cell counts, Legend (LEGN) had decided to pause the trial and notified the FDA. “The patient has not experienced drug-related serious adverse events (SAEs) and is being monitored in accordance with the protocol,” the company added.  In October, Allogene (NASDAQ:ALLO) was slapped with a clinical hold by the FDA on its AlloCAR T trials. However, early this year, the company announced that the agency removed the clinical hold.","news_type":1},"isVote":1,"tweetType":1,"viewCount":838,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638839332,"gmtCreate":1645167282946,"gmtModify":1645167307559,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>再也挡不住了","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>再也挡不住了","text":"$金斯瑞生物科技(01548)$再也挡不住了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638839332","isVote":1,"tweetType":1,"viewCount":941,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":631174568,"gmtCreate":1644560666772,"gmtModify":1644560667068,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>祝贺小金，though今天大跌。","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>祝贺小金，though今天大跌。","text":"$金斯瑞生物科技(01548)$祝贺小金，though今天大跌。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/631174568","isVote":1,"tweetType":1,"viewCount":652,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633422548,"gmtCreate":1644292621580,"gmtModify":1644292621950,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>元宵节行情谁预测一下。","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>元宵节行情谁预测一下。","text":"$金斯瑞生物科技(01548)$元宵节行情谁预测一下。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633422548","isVote":1,"tweetType":1,"viewCount":886,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":694175323,"gmtCreate":1641887640164,"gmtModify":1641887640378,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"激励非常重要。","listText":"激励非常重要。","text":"激励非常重要。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/694175323","repostId":"2202276848","repostType":2,"repost":{"id":"2202276848","pubTimestamp":1641827390,"share":"https://www.laohu8.com/m/news/2202276848?lang=&edition=full","pubTime":"2022-01-10 23:09","market":"sh","language":"zh","title":"金斯瑞生物科技向轮值首席执行官柳振宇授予约16.44万股限制性股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2202276848","media":"智通财经","summary":"金斯瑞生物科技(01548)公布，于2022年1月10日，根据2019年限制性股份奖励计划，轮值首席执行官柳振宇被授予约16.44万股限制性股份。 ...","content":"<html><body><div>\n<p>　　<a href=\"https://laohu8.com/S/01548\">金斯瑞生物科技</a>(01548)公布，于2022年1月10日，根据2019年限制性股份奖励计划，轮值首席执行官柳振宇被授予约16.44万股限制性股份。</p>\n<p><strong>关注<a href=\"https://laohu8.com/S/300033\">同花顺</a>财经（ths518），获取更多机会</strong></p>\n<span></span>\n</div></body></html>","source":"tonghuashun","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>金斯瑞生物科技向轮值首席执行官柳振宇授予约16.44万股限制性股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n金斯瑞生物科技向轮值首席执行官柳振宇授予约16.44万股限制性股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-10 23:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://stock.10jqka.com.cn/hks/20220110/c635859552.shtml><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>金斯瑞生物科技(01548)公布，于2022年1月10日，根据2019年限制性股份奖励计划，轮值首席执行官柳振宇被授予约16.44万股限制性股份。\n关注同花顺财经（ths518），获取更多机会</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20220110/c635859552.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/b8906c2117cf409a3cc5087f96741bce","relate_stocks":{"BK1583":"高瓴概念","BK1576":"医药外包概念","01548":"金斯瑞生物科技","BK1141":"生命科学工具和服务"},"source_url":"http://stock.10jqka.com.cn/hks/20220110/c635859552.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/f0343184bd9b9c963ed02b302442e2b8","article_id":"2202276848","content_text":"金斯瑞生物科技(01548)公布，于2022年1月10日，根据2019年限制性股份奖励计划，轮值首席执行官柳振宇被授予约16.44万股限制性股份。\n关注同花顺财经（ths518），获取更多机会","news_type":1},"isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":694948345,"gmtCreate":1641798356737,"gmtModify":1641798356964,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>大腿粗了细了，最终还是粗了","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>大腿粗了细了，最终还是粗了","text":"$金斯瑞生物科技(01548)$大腿粗了细了，最终还是粗了","images":[{"img":"https://static.tigerbbs.com/5aa0a7982c204e62d26cec2689d02a58","width":"1200","height":"2133"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/694948345","isVote":1,"tweetType":1,"viewCount":506,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":694984302,"gmtCreate":1641786707387,"gmtModify":1641786707606,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>好赛道&nbsp;好兆头&nbsp;","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>好赛道&nbsp;好兆头&nbsp;","text":"$金斯瑞生物科技(01548)$好赛道 好兆头","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/694984302","isVote":1,"tweetType":1,"viewCount":273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606172942,"gmtCreate":1638848163281,"gmtModify":1638848267324,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"节奏掌握得不错，高人","listText":"节奏掌握得不错，高人","text":"节奏掌握得不错，高人","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606172942","repostId":"2189681957","repostType":2,"repost":{"id":"2189681957","pubTimestamp":1638836079,"share":"https://www.laohu8.com/m/news/2189681957?lang=&edition=full","pubTime":"2021-12-07 08:14","market":"us","language":"zh","title":"金斯瑞生物科技(01548.HK)非全资附属向日本提交骨髓瘤新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2189681957","media":"AAFN","summary":"金斯瑞生物科技  公布，其非全资附属公司「传奇生物」宣布，其合作夥伴杨森制药今天向日本厚生劳动省提交西达基奥仑赛的新药申请。西达基奥仑赛是一款在研的靶向B细胞成熟抗原嵌合抗原受体T细胞疗法，用於治疗复发或难治性多发性骨髓瘤成人患者。(na/w)~阿思达克财经新闻网址: www.aastocks.com","content":"<html><body><p><a href=\"https://laohu8.com/S/01548\">金斯瑞生物科技</a>  公布，其非全资附属公司「<a href=\"https://laohu8.com/S/LEGN\">传奇生物</a>」宣布，其合作夥伴杨森制药今天向日本厚生劳动省提交西达基奥仑赛的新药申请。西达基奥仑赛是一款在研的靶向B细胞成熟抗原嵌合抗原受体T细胞疗法，用於治疗复发或难治性多发性骨髓瘤成人患者。(na/w)~阿思达克财经新闻网址: www.aastocks.com</p></body></html>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>金斯瑞生物科技(01548.HK)非全资附属向日本提交骨髓瘤新药申请</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n金斯瑞生物科技(01548.HK)非全资附属向日本提交骨髓瘤新药申请\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 08:14 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1147960&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>金斯瑞生物科技  公布，其非全资附属公司「传奇生物」宣布，其合作夥伴杨森制药今天向日本厚生劳动省提交西达基奥仑赛的新药申请。西达基奥仑赛是一款在研的靶向B细胞成熟抗原嵌合抗原受体T细胞疗法，用於治疗复发或难治性多发性骨髓瘤成人患者。(na/w)~阿思达克财经新闻网址: www.aastocks.com</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1147960&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","relate_stocks":{"BK1141":"生命科学工具和服务","01548":"金斯瑞生物科技","BK1583":"高瓴概念","BK1576":"医药外包概念"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1147960&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2189681957","content_text":"金斯瑞生物科技  公布，其非全资附属公司「传奇生物」宣布，其合作夥伴杨森制药今天向日本厚生劳动省提交西达基奥仑赛的新药申请。西达基奥仑赛是一款在研的靶向B细胞成熟抗原嵌合抗原受体T细胞疗法，用於治疗复发或难治性多发性骨髓瘤成人患者。(na/w)~阿思达克财经新闻网址: www.aastocks.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606176427,"gmtCreate":1638848115595,"gmtModify":1638852157566,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"造福各国患者","listText":"造福各国患者","text":"造福各国患者","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606176427","repostId":"2189681957","repostType":2,"repost":{"id":"2189681957","pubTimestamp":1638836079,"share":"https://www.laohu8.com/m/news/2189681957?lang=&edition=full","pubTime":"2021-12-07 08:14","market":"us","language":"zh","title":"金斯瑞生物科技(01548.HK)非全资附属向日本提交骨髓瘤新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2189681957","media":"AAFN","summary":"金斯瑞生物科技  公布，其非全资附属公司「传奇生物」宣布，其合作夥伴杨森制药今天向日本厚生劳动省提交西达基奥仑赛的新药申请。西达基奥仑赛是一款在研的靶向B细胞成熟抗原嵌合抗原受体T细胞疗法，用於治疗复发或难治性多发性骨髓瘤成人患者。(na/w)~阿思达克财经新闻网址: www.aastocks.com","content":"<html><body><p><a href=\"https://laohu8.com/S/01548\">金斯瑞生物科技</a>  公布，其非全资附属公司「<a href=\"https://laohu8.com/S/LEGN\">传奇生物</a>」宣布，其合作夥伴杨森制药今天向日本厚生劳动省提交西达基奥仑赛的新药申请。西达基奥仑赛是一款在研的靶向B细胞成熟抗原嵌合抗原受体T细胞疗法，用於治疗复发或难治性多发性骨髓瘤成人患者。(na/w)~阿思达克财经新闻网址: www.aastocks.com</p></body></html>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>金斯瑞生物科技(01548.HK)非全资附属向日本提交骨髓瘤新药申请</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n金斯瑞生物科技(01548.HK)非全资附属向日本提交骨髓瘤新药申请\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 08:14 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1147960&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>金斯瑞生物科技  公布，其非全资附属公司「传奇生物」宣布，其合作夥伴杨森制药今天向日本厚生劳动省提交西达基奥仑赛的新药申请。西达基奥仑赛是一款在研的靶向B细胞成熟抗原嵌合抗原受体T细胞疗法，用於治疗复发或难治性多发性骨髓瘤成人患者。(na/w)~阿思达克财经新闻网址: www.aastocks.com</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1147960&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","relate_stocks":{"BK1141":"生命科学工具和服务","01548":"金斯瑞生物科技","BK1583":"高瓴概念","BK1576":"医药外包概念"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1147960&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2189681957","content_text":"金斯瑞生物科技  公布，其非全资附属公司「传奇生物」宣布，其合作夥伴杨森制药今天向日本厚生劳动省提交西达基奥仑赛的新药申请。西达基奥仑赛是一款在研的靶向B细胞成熟抗原嵌合抗原受体T细胞疗法，用於治疗复发或难治性多发性骨髓瘤成人患者。(na/w)~阿思达克财经新闻网址: www.aastocks.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":343,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878823329,"gmtCreate":1637167858251,"gmtModify":1637167858403,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RBLX\">$Roblox Corporation(RBLX)$</a>伟大的游戏公司，游戏生态。而游戏精神，包括游戏的教育性，动手性，影响深远。游戏，不仅少儿尿泥时。","listText":"<a href=\"https://laohu8.com/S/RBLX\">$Roblox Corporation(RBLX)$</a>伟大的游戏公司，游戏生态。而游戏精神，包括游戏的教育性，动手性，影响深远。游戏，不仅少儿尿泥时。","text":"$Roblox Corporation(RBLX)$伟大的游戏公司，游戏生态。而游戏精神，包括游戏的教育性，动手性，影响深远。游戏，不仅少儿尿泥时。","images":[{"img":"https://static.tigerbbs.com/207f100328893ae575eae0590b72d39b","width":"1200","height":"2133"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878823329","isVote":1,"tweetType":1,"viewCount":531,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":871624200,"gmtCreate":1637067200703,"gmtModify":1637067201065,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>跑百里者半九十","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>跑百里者半九十","text":"$金斯瑞生物科技(01548)$跑百里者半九十","images":[{"img":"https://static.tigerbbs.com/a598352e469e4ce390685364fec8db08","width":"1200","height":"2133"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871624200","isVote":1,"tweetType":1,"viewCount":423,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":871004158,"gmtCreate":1636990869441,"gmtModify":1636990869549,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LEGN\">$传奇生物(LEGN)$</a>再次冲击50","listText":"<a href=\"https://laohu8.com/S/LEGN\">$传奇生物(LEGN)$</a>再次冲击50","text":"$传奇生物(LEGN)$再次冲击50","images":[{"img":"https://static.tigerbbs.com/84d1ee5bcc86a0ef6b319bca463370b8","width":"1200","height":"2334"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871004158","isVote":1,"tweetType":1,"viewCount":408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":879636757,"gmtCreate":1636714498867,"gmtModify":1636714498976,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"问题不大。","listText":"问题不大。","text":"问题不大。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879636757","repostId":"1161897370","repostType":4,"repost":{"id":"1161897370","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636695325,"share":"https://www.laohu8.com/m/news/1161897370?lang=&edition=full","pubTime":"2021-11-12 13:35","market":"other","language":"zh","title":"港股电子烟概念午后拉涨，华宝国际一度涨超21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161897370","media":"老虎资讯综合","summary":"11月12日，港股电子烟概念午后拉涨，华宝国际一度涨超21%，比亚迪电子涨超6%，中烟香港涨超5%，思摩尔国际涨超4%\n据市场消息，国家局今天组织召开了电子烟国家标准会议，主要内容涉及：1.电子烟烟液","content":"<p>11月12日，港股电子烟概念午后拉涨，<a href=\"https://laohu8.com/S/00336\">华宝国际</a>一度涨超21%，<a href=\"https://laohu8.com/S/00285\">比亚迪电子</a>涨超6%，<a href=\"https://laohu8.com/S/06055\">中烟香港</a>涨超5%，<a href=\"https://laohu8.com/S/06969\">思摩尔国际</a>涨超4%</p>\n<p>据市场消息，国家局今天组织召开了电子烟国家标准会议，主要内容涉及：1.电子烟烟液允许使用的添加剂白名单为122种，这意味着大量水果味不能生产销售。2.尼古丁最高限量20 mg/ml，雾化温度＜350℃。3、现在市面上本草烟弹可能被认定为固态电子烟。</p>\n<p><img src=\"https://static.tigerbbs.com/22eea14255ab4c04993e6d94777b4c06\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股电子烟概念午后拉涨，华宝国际一度涨超21%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股电子烟概念午后拉涨，华宝国际一度涨超21%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-11-12 13:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>11月12日，港股电子烟概念午后拉涨，<a href=\"https://laohu8.com/S/00336\">华宝国际</a>一度涨超21%，<a href=\"https://laohu8.com/S/00285\">比亚迪电子</a>涨超6%，<a href=\"https://laohu8.com/S/06055\">中烟香港</a>涨超5%，<a href=\"https://laohu8.com/S/06969\">思摩尔国际</a>涨超4%</p>\n<p>据市场消息，国家局今天组织召开了电子烟国家标准会议，主要内容涉及：1.电子烟烟液允许使用的添加剂白名单为122种，这意味着大量水果味不能生产销售。2.尼古丁最高限量20 mg/ml，雾化温度＜350℃。3、现在市面上本草烟弹可能被认定为固态电子烟。</p>\n<p><img src=\"https://static.tigerbbs.com/22eea14255ab4c04993e6d94777b4c06\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","relate_stocks":{"06969":"思摩尔国际","00336":"华宝国际"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161897370","content_text":"11月12日，港股电子烟概念午后拉涨，华宝国际一度涨超21%，比亚迪电子涨超6%，中烟香港涨超5%，思摩尔国际涨超4%\n据市场消息，国家局今天组织召开了电子烟国家标准会议，主要内容涉及：1.电子烟烟液允许使用的添加剂白名单为122种，这意味着大量水果味不能生产销售。2.尼古丁最高限量20 mg/ml，雾化温度＜350℃。3、现在市面上本草烟弹可能被认定为固态电子烟。","news_type":1},"isVote":1,"tweetType":1,"viewCount":428,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":958390028,"gmtCreate":1591156748464,"gmtModify":1704194580660,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LEGN\">$传奇生物(LEGN)$</a>我是从新加坡参与老虎证券的，客服说，不能申购传奇。白高兴啦","listText":"<a href=\"https://laohu8.com/S/LEGN\">$传奇生物(LEGN)$</a>我是从新加坡参与老虎证券的，客服说，不能申购传奇。白高兴啦","text":"$传奇生物(LEGN)$我是从新加坡参与老虎证券的，客服说，不能申购传奇。白高兴啦","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":12,"repostSize":0,"link":"https://laohu8.com/post/958390028","isVote":1,"tweetType":1,"viewCount":3484,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3439719657064909","authorId":"3439719657064909","name":"虎吃牛牛","avatar":"https://static.tigerbbs.com/a86b09a966ea9a919ccbd1d6918e3577","crmLevel":4,"crmLevelSwitch":1,"idStr":"3439719657064909","authorIdStr":"3439719657064909"},"content":"新加坡地区不是没有社区的吗","text":"新加坡地区不是没有社区的吗","html":"新加坡地区不是没有社区的吗"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":168103062,"gmtCreate":1623956862256,"gmtModify":1634025271026,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>傻小子睡凉炕一般，在9建仓了。现在到8了，加仓300%。基于今晚对该行业一个初步学习判断。国内最大，国际高速增长!&nbsp;最终政策是互动中形成。包括咱们加仓也是一个小小小小因素。吃喝玩乐行业，有他自身逻辑。增加国家税收，用在教育，用在科技!","listText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>傻小子睡凉炕一般，在9建仓了。现在到8了，加仓300%。基于今晚对该行业一个初步学习判断。国内最大，国际高速增长!&nbsp;最终政策是互动中形成。包括咱们加仓也是一个小小小小因素。吃喝玩乐行业，有他自身逻辑。增加国家税收，用在教育，用在科技!","text":"$RLX科技(RLX)$傻小子睡凉炕一般，在9建仓了。现在到8了，加仓300%。基于今晚对该行业一个初步学习判断。国内最大，国际高速增长! 最终政策是互动中形成。包括咱们加仓也是一个小小小小因素。吃喝玩乐行业，有他自身逻辑。增加国家税收，用在教育，用在科技!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/168103062","isVote":1,"tweetType":1,"viewCount":7542,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3548408641040880","authorId":"3548408641040880","name":"小良i","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3548408641040880","authorIdStr":"3548408641040880"},"content":"主要中国政府不可能禁止电子烟，如果中国都禁电子烟了，那亚非拉国家都要学着禁电子烟，传统烟草各国都能自己身材，唯有电子烟都是中国造，以后全球都吸电子烟等于中国向全世界收人头税","text":"主要中国政府不可能禁止电子烟，如果中国都禁电子烟了，那亚非拉国家都要学着禁电子烟，传统烟草各国都能自己身材，唯有电子烟都是中国造，以后全球都吸电子烟等于中国向全世界收人头税","html":"主要中国政府不可能禁止电子烟，如果中国都禁电子烟了，那亚非拉国家都要学着禁电子烟，传统烟草各国都能自己身材，唯有电子烟都是中国造，以后全球都吸电子烟等于中国向全世界收人头税"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":833127702,"gmtCreate":1629211619106,"gmtModify":1631888436972,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TWTR\">$Twitter(TWTR)$</a>建仓3理由for the future,buy the future,&nbsp;of the future","listText":"<a href=\"https://laohu8.com/S/TWTR\">$Twitter(TWTR)$</a>建仓3理由for the future,buy the future,&nbsp;of the future","text":"$Twitter(TWTR)$建仓3理由for the future,buy the future, of the future","images":[{"img":"https://static.tigerbbs.com/971e6baf6004eb50f16a559150c400c5","width":"1200","height":"2133"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":3,"link":"https://laohu8.com/post/833127702","isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":806654413,"gmtCreate":1627654869132,"gmtModify":1633757377729,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BILI\">$哔哩哔哩(BILI)$</a>今天下午，以第一亿多名会员身份体验了一小时。傍晚忍不住，又加仓了。","listText":"<a href=\"https://laohu8.com/S/BILI\">$哔哩哔哩(BILI)$</a>今天下午，以第一亿多名会员身份体验了一小时。傍晚忍不住，又加仓了。","text":"$哔哩哔哩(BILI)$今天下午，以第一亿多名会员身份体验了一小时。傍晚忍不住，又加仓了。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":1,"link":"https://laohu8.com/post/806654413","isVote":1,"tweetType":1,"viewCount":2888,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3577842877454251","authorId":"3577842877454251","name":"模拟小人物","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3577842877454251","authorIdStr":"3577842877454251"},"content":"现在b站有很多为了赞评论投币流量而无脑蹭热度的up和用户 所以要小心点了","text":"现在b站有很多为了赞评论投币流量而无脑蹭热度的up和用户 所以要小心点了","html":"现在b站有很多为了赞评论投币流量而无脑蹭热度的up和用户 所以要小心点了"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":140250461,"gmtCreate":1625663341453,"gmtModify":1633938618751,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>看看英美烟草。市值，和美股价格，单位是英镑!","listText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>看看英美烟草。市值，和美股价格，单位是英镑!","text":"$RLX科技(RLX)$看看英美烟草。市值，和美股价格，单位是英镑!","images":[{"img":"https://static.tigerbbs.com/19ed1360908313b43bb405dc12924ed9","width":"1200","height":"2640"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/140250461","isVote":1,"tweetType":1,"viewCount":1839,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":166792922,"gmtCreate":1624024528066,"gmtModify":1631888882594,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"New-Bie。新人。边玩，边学，边买。希望成为牛B之人，与B站共成长。","listText":"New-Bie。新人。边玩，边学，边买。希望成为牛B之人，与B站共成长。","text":"New-Bie。新人。边玩，边学，边买。希望成为牛B之人，与B站共成长。","images":[{"img":"https://static.tigerbbs.com/23ef2c06b29f444ce33423484da0e365","width":"1200","height":"3444"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166792922","isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":885699248,"gmtCreate":1631781983584,"gmtModify":1631884246967,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>让我抽根烟&nbsp;又恐琼楼玉宇&nbsp;风大点不着火","listText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>让我抽根烟&nbsp;又恐琼楼玉宇&nbsp;风大点不着火","text":"$RLX科技(RLX)$让我抽根烟 又恐琼楼玉宇 风大点不着火","images":[{"img":"https://static.tigerbbs.com/ce99edc55d87c9327e85b97959c6068e","width":"1200","height":"2133"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/885699248","isVote":1,"tweetType":1,"viewCount":890,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":190885414,"gmtCreate":1620611175438,"gmtModify":1631888994595,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>加油啦 20不是事","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>加油啦 20不是事","text":"$金斯瑞生物科技(01548)$加油啦 20不是事","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":1,"link":"https://laohu8.com/post/190885414","isVote":1,"tweetType":1,"viewCount":1050,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3553997027627753","authorId":"3553997027627753","name":"香港友邦娜娜涨","avatar":"https://static.tigerbbs.com/46cf30dba4a58e97dba2fa8a9332b78d","crmLevel":2,"crmLevelSwitch":0,"idStr":"3553997027627753","authorIdStr":"3553997027627753"},"content":"加个10，30不是事儿","text":"加个10，30不是事儿","html":"加个10，30不是事儿"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":128820830,"gmtCreate":1624510639520,"gmtModify":1631888994568,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>感谢小金。赚了超过150%。昨晚同时加仓传奇。在乱世中，能够纵横捭阖，又布局比利时，蛰伏，厚积薄发多少年，牛了上半年，期待下半年飞龙在天。","listText":"<a href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a>感谢小金。赚了超过150%。昨晚同时加仓传奇。在乱世中，能够纵横捭阖，又布局比利时，蛰伏，厚积薄发多少年，牛了上半年，期待下半年飞龙在天。","text":"$金斯瑞生物科技(01548)$感谢小金。赚了超过150%。昨晚同时加仓传奇。在乱世中，能够纵横捭阖，又布局比利时，蛰伏，厚积薄发多少年，牛了上半年，期待下半年飞龙在天。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/128820830","isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3574996429121752","authorId":"3574996429121752","name":"TingDong","avatar":"https://static.tigerbbs.com/eb1856f6ecea169a05d2145bc9e19a10","crmLevel":2,"crmLevelSwitch":0,"idStr":"3574996429121752","authorIdStr":"3574996429121752"},"content":"腻害，请问兄弟，之前是怎么看好这个股票的","text":"腻害，请问兄弟，之前是怎么看好这个股票的","html":"腻害，请问兄弟，之前是怎么看好这个股票的"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":170202224,"gmtCreate":1626432697268,"gmtModify":1633926809743,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>我的看法，见图如我。","listText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>我的看法，见图如我。","text":"$RLX科技(RLX)$我的看法，见图如我。","images":[{"img":"https://static.tigerbbs.com/7715d35d7b0ca540599e68edfd998c6c","width":"1200","height":"2640"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/170202224","isVote":1,"tweetType":1,"viewCount":946,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4088863030382730","authorId":"4088863030382730","name":"淘气小宝","avatar":"https://static.tigerbbs.com/53252edf59f4d2b5a3518e2e8f0e9e95","crmLevel":1,"crmLevelSwitch":0,"idStr":"4088863030382730","authorIdStr":"4088863030382730"},"content":"2000个账号算屁，不打掉20万个都是玩","text":"2000个账号算屁，不打掉20万个都是玩","html":"2000个账号算屁，不打掉20万个都是玩"}],"imageCount":1,"langContent":"CN","totalScore":0},{"id":122280624,"gmtCreate":1624622877668,"gmtModify":1633950432117,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>吃喝PD抽，横亘上千年。有人说更健康，有人说更时尚。还有人说，消费要升级。不敢比茅台，不敢比游戏。悦刻其实不用比，字面意思就是\"活在当下\"嘛。","listText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>吃喝PD抽，横亘上千年。有人说更健康，有人说更时尚。还有人说，消费要升级。不敢比茅台，不敢比游戏。悦刻其实不用比，字面意思就是\"活在当下\"嘛。","text":"$RLX科技(RLX)$吃喝PD抽，横亘上千年。有人说更健康，有人说更时尚。还有人说，消费要升级。不敢比茅台，不敢比游戏。悦刻其实不用比，字面意思就是\"活在当下\"嘛。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/122280624","isVote":1,"tweetType":1,"viewCount":444,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":940943688,"gmtCreate":1593662223244,"gmtModify":1704202735455,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/00981\">$中芯国际(00981)$</a> 请问，在老虎可以买到科创版中芯吗","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/00981\">$中芯国际(00981)$</a> 请问，在老虎可以买到科创版中芯吗","text":"$中芯国际(00981)$ 请问，在老虎可以买到科创版中芯吗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/940943688","isVote":1,"tweetType":1,"viewCount":1740,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":949119924,"gmtCreate":1594188677068,"gmtModify":1704204284403,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a> **一片骂声聒噪中，于是乎我加仓了。这就是明净心灵，嘿嘿嘿","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/01548\">$金斯瑞生物科技(01548)$</a> **一片骂声聒噪中，于是乎我加仓了。这就是明净心灵，嘿嘿嘿","text":"$金斯瑞生物科技(01548)$ **一片骂声聒噪中，于是乎我加仓了。这就是明净心灵，嘿嘿嘿","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/949119924","isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":895949575,"gmtCreate":1628720287397,"gmtModify":1633744956629,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"伟大的基建 你学习了东方智慧","listText":"伟大的基建 你学习了东方智慧","text":"伟大的基建 你学习了东方智慧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/895949575","repostId":"1164060654","repostType":4,"repost":{"id":"1164060654","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628695939,"share":"https://www.laohu8.com/m/news/1164060654?lang=&edition=full","pubTime":"2021-08-11 23:32","market":"us","language":"zh","title":"美股区块链概念股集体上涨, Coinbase涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1164060654","media":"老虎资讯综合","summary":"8月11日，美股区块链概念股集体上涨，$比特矿业(BTCM)$涨超16%，$第九城市(NCTY)$涨超7%，Coinbase、$嘉楠科技(CAN)$涨超6%。\n\n\n消息面上，Coinbase昨日盘后公布业绩显示，二季度营收22.3亿美元，市场预期17.47亿美元；净利润15.93亿美元，同比增长近49倍，大超市场预期的5.66亿美元。\n\n\n另外，Coingecko数据显示，加密货币总市值重返2万亿美元上方，24小时涨幅3.8%。比特币价格现报46602.12美元/枚，24小时涨幅3%，市值占比为43.5%。","content":"<p>8月11日，美股区块链概念股集体上涨，<a href=\"https://laohu8.com/S/BTCM\">比特矿业</a>涨超16%，<a href=\"https://laohu8.com/S/NCTY\">第九城市</a>涨超7%，Coinbase、<a href=\"https://laohu8.com/S/CAN\">嘉楠科技</a>涨超6%。</p>\n<p>消息面上，Coinbase昨日盘后公布业绩显示，二季度营收22.3亿美元，市场预期17.47亿美元；净利润15.93亿美元，同比增长近49倍，大超市场预期的5.66亿美元。</p>\n<p>另外，Coingecko数据显示，加密货币总市值重返2万亿美元上方，24小时涨幅3.8%。比特币价格现报46602.12美元/枚，24小时涨幅3%，市值占比为43.5%。<img src=\"https://static.tigerbbs.com/7e8fd14f12c9ef3d296b39219ba813a4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股区块链概念股集体上涨, Coinbase涨超6%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股区块链概念股集体上涨, Coinbase涨超6%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-08-11 23:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>8月11日，美股区块链概念股集体上涨，<a href=\"https://laohu8.com/S/BTCM\">比特矿业</a>涨超16%，<a href=\"https://laohu8.com/S/NCTY\">第九城市</a>涨超7%，Coinbase、<a href=\"https://laohu8.com/S/CAN\">嘉楠科技</a>涨超6%。</p>\n<p>消息面上，Coinbase昨日盘后公布业绩显示，二季度营收22.3亿美元，市场预期17.47亿美元；净利润15.93亿美元，同比增长近49倍，大超市场预期的5.66亿美元。</p>\n<p>另外，Coingecko数据显示，加密货币总市值重返2万亿美元上方，24小时涨幅3.8%。比特币价格现报46602.12美元/枚，24小时涨幅3%，市值占比为43.5%。<img src=\"https://static.tigerbbs.com/7e8fd14f12c9ef3d296b39219ba813a4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/38437c39c3981e6d4f1a65407a610d0f","relate_stocks":{"NCTY":"第九城市","CAN":"嘉楠科技","BTCM":"BIT Mining"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164060654","content_text":"8月11日，美股区块链概念股集体上涨，比特矿业涨超16%，第九城市涨超7%，Coinbase、嘉楠科技涨超6%。\n消息面上，Coinbase昨日盘后公布业绩显示，二季度营收22.3亿美元，市场预期17.47亿美元；净利润15.93亿美元，同比增长近49倍，大超市场预期的5.66亿美元。\n另外，Coingecko数据显示，加密货币总市值重返2万亿美元上方，24小时涨幅3.8%。比特币价格现报46602.12美元/枚，24小时涨幅3%，市值占比为43.5%。","news_type":1},"isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":898656698,"gmtCreate":1628495927714,"gmtModify":1631889242567,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02158\">$医渡科技(02158)$</a>建仓成功。","listText":"<a href=\"https://laohu8.com/S/02158\">$医渡科技(02158)$</a>建仓成功。","text":"$医渡科技(02158)$建仓成功。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/898656698","isVote":1,"tweetType":1,"viewCount":3981,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":800539140,"gmtCreate":1627307748380,"gmtModify":1633766292948,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>我把该股起名为吞吐洪荒。大气不。","listText":"<a href=\"https://laohu8.com/S/RLX\">$RLX科技(RLX)$</a>我把该股起名为吞吐洪荒。大气不。","text":"$RLX科技(RLX)$我把该股起名为吞吐洪荒。大气不。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/800539140","isVote":1,"tweetType":1,"viewCount":600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":144329078,"gmtCreate":1626269150094,"gmtModify":1631885975633,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LEGN\">$传奇生物(LEGN)$</a>到底是金斯瑞创造了传奇，还是传奇要成就金斯瑞？你们什么想法。","listText":"<a href=\"https://laohu8.com/S/LEGN\">$传奇生物(LEGN)$</a>到底是金斯瑞创造了传奇，还是传奇要成就金斯瑞？你们什么想法。","text":"$传奇生物(LEGN)$到底是金斯瑞创造了传奇，还是传奇要成就金斯瑞？你们什么想法。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/144329078","isVote":1,"tweetType":1,"viewCount":488,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3455839179733892","authorId":"3455839179733892","name":"叨客宁宁","avatar":"https://static.tigerbbs.com/bc0f5f90d8513b2582d2721a3cf291cd","crmLevel":4,"crmLevelSwitch":1,"idStr":"3455839179733892","authorIdStr":"3455839179733892"},"content":"看来你在金斯瑞上挣到了不少。我从牢房里里把这家公司的老板找出来时，你也同时开始关注了，而且你关注的比我更持久。你目睹了金斯瑞的整段超级行情，我提前下车了。","text":"看来你在金斯瑞上挣到了不少。我从牢房里里把这家公司的老板找出来时，你也同时开始关注了，而且你关注的比我更持久。你目睹了金斯瑞的整段超级行情，我提前下车了。","html":"看来你在金斯瑞上挣到了不少。我从牢房里里把这家公司的老板找出来时，你也同时开始关注了，而且你关注的比我更持久。你目睹了金斯瑞的整段超级行情，我提前下车了。"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":189331257,"gmtCreate":1623244596479,"gmtModify":1631884772275,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PATH\">$UiPath(PATH)$</a>建仓了&nbsp;","listText":"<a href=\"https://laohu8.com/S/PATH\">$UiPath(PATH)$</a>建仓了&nbsp;","text":"$UiPath(PATH)$建仓了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/189331257","isVote":1,"tweetType":1,"viewCount":452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":339348802,"gmtCreate":1608777951106,"gmtModify":1703736716108,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CJLU.SI\">$网联宽频信托(CJLU.SI)$</a> 据说分红2分钱?","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CJLU.SI\">$网联宽频信托(CJLU.SI)$</a> 据说分红2分钱?","text":"$网联宽频信托(CJLU.SI)$ 据说分红2分钱?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/339348802","isVote":1,"tweetType":1,"viewCount":1257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":954324254,"gmtCreate":1592807133978,"gmtModify":1704200154096,"author":{"id":"3486361727758741","authorId":"3486361727758741","name":"Rio999","avatar":"https://static.tigerbbs.com/c1e4178e32cb0fcff4b50f4dce9cc6b4","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3486361727758741","authorIdStr":"3486361727758741"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/00981\">$中芯国际(00981)$</a> 持有好几年，风风雨雨。终于小有斩获，CHEERS! 感觉自己和中芯一起成长，一起经历了风风雨雨。今天又是一个历史新高。这不是天上掉馅饼。","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/00981\">$中芯国际(00981)$</a> 持有好几年，风风雨雨。终于小有斩获，CHEERS! 感觉自己和中芯一起成长，一起经历了风风雨雨。今天又是一个历史新高。这不是天上掉馅饼。","text":"$中芯国际(00981)$ 持有好几年，风风雨雨。终于小有斩获，CHEERS! 感觉自己和中芯一起成长，一起经历了风风雨雨。今天又是一个历史新高。这不是天上掉馅饼。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/954324254","isVote":1,"tweetType":1,"viewCount":910,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}